Accuracy Coverage Pricing Help Centre Contact
Perkinelmer, Inc.

Perkinelmer, Inc. (PKI) Dividends

Dividend Summary:

The next Perkinelmer, Inc. dividend will go ex in 14 days for 7c and will be paid in 1 month.
The previous Perkinelmer, Inc. dividend was 7c and it went ex 3 months ago and it was paid 2 months ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 14.4.
Country:
United States
Exchange:
New York Stock Exchange
Sector:
Technology Hardware & Equipment
  Previous Dividend Next Dividend
Status: Paid Declared
Type: Quarterly Quarterly
Per Share: 7c Sign Up Required
Ex-div Date: Thu 16 Jul 2020 Thu 15 Oct 2020
Pay Date: Fri 07 Aug 2020 Fri 06 Nov 2020
Your Holding: 100 shares 100 shares
Your Payment: $7.00 $7.00

Dividend Payment Calculator

Enter the number of shares you hold:

shares
Calculate Payment

Free dividend email notifications

Declared and Forecast Perkinelmer, Inc. Dividends

Ex-Div Date Pay Date Type Amount Currency Status
18 Jul 2012 10 Aug 2012 Quarterly 7c USD Paid
17 Oct 2012 09 Nov 2012 Quarterly 7c USD Paid
16 Jan 2013 08 Feb 2013 Quarterly 7c USD Paid
17 Apr 2013 10 May 2013 Quarterly 7c USD Paid
17 Jul 2013 09 Aug 2013 Quarterly 7c USD Paid
16 Oct 2013 08 Nov 2013 Quarterly 7c USD Paid
15 Jan 2014 07 Feb 2014 Quarterly 7c USD Paid
15 Apr 2014 09 May 2014 Quarterly 7c USD Paid
16 Jul 2014 08 Aug 2014 Quarterly 7c USD Paid
15 Oct 2014 07 Nov 2014 Quarterly 7c USD Paid
14 Jan 2015 06 Feb 2015 Quarterly 7c USD Paid
15 Apr 2015 11 May 2015 Quarterly 7c USD Paid
15 Jul 2015 10 Aug 2015 Quarterly 7c USD Paid
14 Oct 2015 10 Nov 2015 Quarterly 7c USD Paid
13 Jan 2016 10 Feb 2016 Quarterly 7c USD Paid
13 Apr 2016 10 May 2016 Quarterly 7c USD Paid
13 Jul 2016 10 Aug 2016 Quarterly 7c USD Paid
12 Oct 2016 10 Nov 2016 Quarterly 7c USD Paid
18 Jan 2017 10 Feb 2017 Quarterly 7c USD Paid
11 Apr 2017 10 May 2017 Quarterly 7c USD Paid
19 Jul 2017 10 Aug 2017 Quarterly 7c USD Paid
19 Oct 2017 10 Nov 2017 Quarterly 7c USD Paid
18 Jan 2018 09 Feb 2018 Quarterly 7c USD Paid
12 Apr 2018 10 May 2018 Quarterly 7c USD Paid
19 Jul 2018 10 Aug 2018 Quarterly 7c USD Paid
18 Oct 2018 09 Nov 2018 Quarterly 7c USD Paid
17 Jan 2019 08 Feb 2019 Quarterly 7c USD Paid
17 Apr 2019 10 May 2019 Quarterly 7c USD Paid
18 Jul 2019 09 Aug 2019 Quarterly 7c USD Paid
17 Oct 2019 08 Nov 2019 Quarterly 7c USD Paid
16 Jan 2020 07 Feb 2020 Quarterly 7c USD Paid
16 Apr 2020 08 May 2020 Quarterly 7c USD Paid
16 Jul 2020 07 Aug 2020 Quarterly 7c USD Paid
15 Oct 2020 06 Nov 2020 Quarterly Sign Up Required USD Declared
14 Jan 2021 05 Feb 2021 Quarterly Sign Up Required USD Forecast
15 Apr 2021 10 May 2021 Quarterly Sign Up Required USD Forecast
15 Jul 2021 06 Aug 2021 Quarterly Sign Up Required USD Forecast
14 Oct 2021 05 Nov 2021 Quarterly Sign Up Required USD Forecast
13 Jan 2022 04 Feb 2022 Quarterly Sign Up Required USD Forecast
13 Apr 2022 10 May 2022 Quarterly Sign Up Required USD Forecast
14 Jul 2022 05 Aug 2022 Quarterly Sign Up Required USD Forecast
13 Oct 2022 04 Nov 2022 Quarterly Sign Up Required USD Forecast
19 Jan 2023 10 Feb 2023 Quarterly Sign Up Required USD Forecast
13 Apr 2023 10 May 2023 Quarterly Sign Up Required USD Forecast
20 Jul 2023 11 Aug 2023 Quarterly Sign Up Required USD Forecast
19 Oct 2023 10 Nov 2023 Quarterly Sign Up Required USD Forecast
18 Jan 2024 09 Feb 2024 Quarterly Sign Up Required USD Forecast
18 Apr 2024 10 May 2024 Quarterly Sign Up Required USD Forecast
18 Jul 2024 09 Aug 2024 Quarterly Sign Up Required USD Forecast
17 Oct 2024 08 Nov 2024 Quarterly Sign Up Required USD Forecast
16 Jan 2025 07 Feb 2025 Quarterly Sign Up Required USD Forecast
17 Apr 2025 09 May 2025 Quarterly Sign Up Required USD Forecast

How accurate are our Perkinelmer, Inc. forecasts?

Prediction Date Dividend Date Forecast Amount Actual Amount Accuracy
07 Aug 2019 15 Oct 2020 7c 7c 100% πŸ˜„
07 Aug 2019 16 Jul 2020 7c 7c 100% πŸ˜„
07 Aug 2019 16 Apr 2020 7c 7c 100% πŸ˜„
07 Aug 2019 16 Jan 2020 7c 7c 100% πŸ˜„
Average Perkinelmer, Inc. Forecast Accuracy 100% πŸ˜„

Access our Perkinelmer, Inc. dividend forecasts and the suite of investor tools free for 30 days.

Try DividendMax free for 30 days

About Perkinelmer, Inc.

PerkinElmer, Inc., incorporated on November 13, 1947, is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics.

Discovery & Analytical Solutions

The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. For the environmental market, it develops and provides analytical technologies, solutions and services that enable its customers to understand the characterization and health of many aspects of environment, including air, water and soil. The Company's technologies are used to detect and help reduce the impact products and industrial processes may have on the environment. For food market, it provides various solutions that help farmers and food producers provide a growing population with food that is safe and nutritious. The Company's instruments are also used to detect the presence of potentially dangerous contaminants, such as lead and mercury in milk. Its solutions can also be used to identify the origin of food products such as olive oil, which helps prevent counterfeiting. Its methods and analyses are transferable throughout the supply chain so its customers are able to keep pace with industry standards as well as governmental regulations and certifications.

The Company provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. The Company's industrial instrumentation is used by customers focusing on quality assurance standards. In the life science research market, it provides a suite of solutions including reagents, informatics, and detection and imaging technologies that enable scientists to increase life science research and facilitate the drug discovery processes. These products, solutions and services support pharmaceutical and biotech companies, and academic institutions. The Company's research portfolio includes a range of systems consisting of imaging, detection and extraction instrumentation for use on in vitro, ex vivo, and in vivo models, analysis hardware and software, plus a range of consumable products, including drug discovery and research reagents. The Company provides services designed to enable its customers in the laboratory services market throughout the world. The Company's OneSource laboratory service business is aligned with customers' needs to accelerate science by enabling gains within their labs.

The Company's principal products and services for Discovery & Analytical Solutions applications in the environmental, food and industrial markets include Clarus series of gas chromatographs, gas chromatographs/mass spectrometers; the TurboMatrix family of sample-handling equipment are used to identify and quantify compounds in the environmental, forensics, food and beverage, hydrocarbon processing/biofuels, materials testing, pharmaceutical and semiconductor industries; Altus UPLC and high performance liquid chromatography (HPLC) advanced liquid chromatography systems providing high throughput and resolution chromatographic separations; AxION 2 TOF MS that is designed to simplify and streamline virtually any analytical workflow and provides mass accuracy, full spectrum capability, speed, sensitivity, and dynamic range; AxION Direct Sample Analysis (DSA), which is a sample introduction system that enables direct sample analysis with minimal sample preparation and no chromatography; Torion T-9 portable GC/MS, a person-portable gas chromatography/ mass spectrometry (GC/MS) system, enabling rapid detection and actionable results to potentially hazardous and emergency environmental conditions; atomic spectroscopy family of instruments, including the AAnalyst/PinAAcle series of atomic absorption spectrometers, the Avio/Optima family of inductively coupled plasma (ICP) optical emission spectrometers and the NexION family of ICP mass spectrometers are used in the environmental and chemical industries, among others, to determine the elemental content of a sample; LAMBDA UV/Vis, a series of spectrophotometers that provide sampling flexibility to enable measuring of a range of sample types, including liquids, powders and solid materials, both in regulated industries as well as quality control/quality assurance (QC/QA) and research applications; 2400 Series II CHNS/O Elemental Analyzer, an organic elemental analyzer, and Perten's Falling Number and Glutomatic instruments that determine the bread baking quality of wheat and flour. It also includes products, such as Avio 200, which is the smallest inductively coupled plasma-optical emission spectroscopy (ICP-OES) on the market, offering the lowest argon consumption of any ICP; QSight Triple Quad LC/MS/MS, which is a flow-based mass spectrometry system that provides high sensitivity; Delta range of milk quality analyzers that ensure the quality of dairy products and are used at Central Milk Testing labs as well as dairy processing facilities around the world, and Bioo Scientific test kits for detection of toxins, veterinary drug residues and contaminants enable testing at various steps in the food value chain.

The Company's principal products and services for Discovery & Analytical Solutions applications in the life sciences research and laboratory services include Phenoptics quantitative pathology research solutions that provide oncologists and cancer immunologists a new way to visualize and measure tumor cells and multiple immune-cell phenotypes simultaneously in FFPE tissue by combining the power of Opal multiplexed immunohistochemistry reagents with the Mantra or Vectra 3 Multispectral Imaging System, enabling visualization and analysis of complex cell interactions in ways that are difficult to achieve with other methods; radiometric detection solutions, including over 1,100 radiochemicals NEN and the Tri-carb, Quantulus GCT families of liquid scintillation analyzers, Wizard2 Gamma counters and MicroBeta2 plate based LSA that are used for beta, gamma and luminescence counting in microplate and vial formats utilized in research, environmental and drug discovery applications; Opera Phenix high content screening system, which is used for sensitive and high speed phenotypic drug screening of complex cellular models; Operetta CLS high content analysis system; Columbus image data storage and analysis system; EnSight multimode plate reader benchtop system that offers well plate imaging alongside label-free and labeled detection technologies for target-based and phenotypic assays; EnVision multilabel plate reader that is targeted towards a range of high-throughput screening applications, including those using AlphaScreen, AlphaLISA and/or AlphaPlex technologies, and G4 PET/X-ray and G8 PET/CT preclinical imaging systems. It also includes products, such as Alpha SureFire Ultra Multiplex Assays that are used for the rapid, sensitive and quantitative detection of phosphoproteins in cells, combined with the measurement of the total amount of the same protein in a single well; CellCarrier Ultra 384-well microplates that are used in high content imaging applications such as phenotypic screening and three-dimensional disease model studies, and PerkinElmer Signals for Translational, a cloud-based data management, aggregation and analysis platform, which integrates experimental and clinical research data from many sources and relates the data to scientifically meaningful concepts in life sciences research market.

Diagnostics

The Company offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help increase the health of families. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. For the diagnostics market, the Diagnostics segment provides early detection for genetic disorders from pregnancy to early childhood, as well as infectious disease testing. Its screening products are designed to provide early insights into the health of expectant mothers during pregnancy and into the health of their babies. Its instruments, reagents and software test and screen for genetic abnormalities, disorders and diseases, including Down syndrome, hypothyroidism, infertility and various metabolic conditions. It also develops the technologies that enable and support sample-to-sequencer workflow using next-generation deoxyribose nucleic acid (DNA) sequencing for applications in oncology, genetic testing and drug discovery. 

The Company's principal products and services for Diagnostics applications in the diagnostics market include DELFIA Xpress screening platform, a complete solution for prenatal and maternal health screening, which includes a continuous loading system; NeoBase Non-derivatized MS/MS kit analyzes newborn blood samples for measurement of amino acids and other metabolic analytes for specific diseases; Specimen Gate informatics data management solution, which is designed specifically for newborn screening laboratories; ViaCord umbilical cord blood banking services for the banking of stem cells harvested from umbilical cord blood and cord tissue, for potential therapeutic application in transplant and regenerative medicine; Next-Generation Sequencing (NGS) Library Prep and multiplexing kits; and EnLite Neonatal TREC System, a screening test for Severe Combined Immunodeficiency, consisting of EnLite Neonatal TREC reagent kits, the Victor EnLite instrument and EnLite Workstation software. Its products and services in applied genomics include Automated liquid handling platforms (JANUS, Sciclone and Zephyr) that offer a choice of robotic solutions in genomics, biotherapeutics, high throughput screening and high content analysis to assist life science research from bench to clinic; LabChip GXII Touch that provides a means of characterizing multiple protein product attributes for research labs through QC, and cell::explorer automated workstation that allows integration of multiple laboratory instrumentation using a centralized robotic interface, allowing high throughput and turnkey-application focused solutions.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%
2010 0.0c 0%
2011 0.0c 0%
2012 28.0c 100%
2013 28.0c 0%
2014 28.0c 0%
2015 28.0c 0%
2016 28.0c 0%
2017 28.0c 0%
2018 28.0c 0%
2019 28.0c 0%
2020 Login required
2021 Login required
2022 Login required
2023 Login required
2024 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
18 Jul 2012 10 Aug 2012 2012 Interim Quarterly Paid 7c
17 Oct 2012 09 Nov 2012 2012 Interim Quarterly Paid 7c
16 Jan 2013 08 Feb 2013 2012 Interim Quarterly Paid 7c
17 Apr 2013 10 May 2013 2012 Final Quarterly Paid 7c
17 Jul 2013 09 Aug 2013 2013 Interim Quarterly Paid 7c
16 Oct 2013 08 Nov 2013 2013 Interim Quarterly Paid 7c
15 Jan 2014 07 Feb 2014 2013 Interim Quarterly Paid 7c
15 Apr 2014 09 May 2014 2013 Final Quarterly Paid 7c
16 Jul 2014 08 Aug 2014 2014 Interim Quarterly Paid 7c
15 Oct 2014 07 Nov 2014 2014 Interim Quarterly Paid 7c
14 Jan 2015 06 Feb 2015 2014 Interim Quarterly Paid 7c
15 Apr 2015 11 May 2015 2014 Final Quarterly Paid 7c
15 Jul 2015 10 Aug 2015 2015 Interim Quarterly Paid 7c
14 Oct 2015 10 Nov 2015 2015 Interim Quarterly Paid 7c
13 Jan 2016 10 Feb 2016 2015 Interim Quarterly Paid 7c
13 Apr 2016 10 May 2016 2015 Final Quarterly Paid 7c
13 Jul 2016 10 Aug 2016 2016 Interim Quarterly Paid 7c
12 Oct 2016 10 Nov 2016 2016 Interim Quarterly Paid 7c
18 Jan 2017 10 Feb 2017 2016 Interim Quarterly Paid 7c
11 Apr 2017 10 May 2017 2016 Final Quarterly Paid 7c
19 Jul 2017 10 Aug 2017 2017 Interim Quarterly Paid 7c
19 Oct 2017 10 Nov 2017 2017 Interim Quarterly Paid 7c
18 Jan 2018 09 Feb 2018 2017 Interim Quarterly Paid 7c
12 Apr 2018 10 May 2018 2017 Final Quarterly Paid 7c
19 Jul 2018 10 Aug 2018 2018 Interim Quarterly Paid 7c
18 Oct 2018 09 Nov 2018 2018 Interim Quarterly Paid 7c
17 Jan 2019 08 Feb 2019 2018 Interim Quarterly Paid 7c
17 Apr 2019 10 May 2019 2018 Final Quarterly Paid 7c
18 Jul 2019 09 Aug 2019 2019 Interim Quarterly Paid 7c
17 Oct 2019 08 Nov 2019 2019 Interim Quarterly Paid 7c
16 Jan 2020 07 Feb 2020 2019 Interim Quarterly Paid 7c
16 Apr 2020 08 May 2020 2019 Final Quarterly Paid 7c
16 Jul 2020 07 Aug 2020 2020 Interim Quarterly Paid 7c
Sign Up Required Sign Up Required 2020 Interim Quarterly Declared Sign Up Required
Sign Up Required Sign Up Required 2020 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2020 Final Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Final Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Final Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Final Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Final Quarterly Forecast Sign Up Required

Perkinelmer, Inc. optimized dividend - 12 month history